Answers are grounded in this paper and cite their sources.
How Wnt signalling including canonical and non-canonical pathways are initiated at the cell surface is not completely understood. Here we report that Wnt receptor Frizzled (Frz) and theco-receptors LRP5 and LRP6 (LRP5/6) directly interact with each other and this interaction is regulated by the LRP6 ectodomain. Importantly, through direct binding to Frz, LRP5/6 are able to prevent Frz-regulated non-canonical pathway activation and further non-canonical pathway-mediated tumour metastasis. Knockdown of endogenous LRP5/6 promotes otherwise-nonaggressive tumour cells to migrate in vitro, whereas a soluble recombinant protein of LRP6 ectodomain suppresses migration and metastasis of otherwise-aggressive tumour cells in vitro and in vivo. Furthermore, the expression level of membrane LRP5/6 correlates inversely with metastasis in mouse and human breast cancer. Our study suggests a previously unrecognized mode of receptor interaction, revealing the mechanism of LRP5/6 in inhibition of non-canonical pathway, and a possible clinical use of the LRP6 ectodomain to impede metastasis. Wnt signalling can be transmitted both through a canonical pathway, via the co-receptors LRP5/6, and through Frz in a non-canonical pathway. Here, the authors demonstrate a direct interaction between Frz and LRP5/6, describing a new mechanism for how these receptors are primed to respond to Wnt ligands.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: